Vnitr Lek 2007, 53(7-8):821-825

Adrenal incidentalomas

M. Kršek
III. interní klinika 1. lékařské fakulty UK a VFN Praha, přednosta prof. MUDr. Štěpán Svačina, DrSc., MBA

Adrenal incidentalomas are called as a disease of modern technology because increased availability and accuracy of imaging techniques lead to increased incidence of incidentally discovered adrenal masses. Adrenal incidentalomas are found in about 0.35-4.36 % of abdominal CT scans performed for purpose other than suspicion of adrenal diseases. However, in autoptic studies the percentage of incidentally discovered adrenal tumours in much higher, in some of then being even more than 20 %. Important component of differential diagnosis is endocrinological examination aimed to reveal potential autonomous hormonal overproduction. Approximately more than 10 % of adrenal incidentalomas is characterized by autonomous cortisol production, 5-10 % is phaeochromocytomas and 5-7 % is aldosteron producing adenomas. Vast majority of adrenal incidentalomas are non-functioning tumours, mainly adenomas. Rational ways and recommendations for screening of hormonal activity of adrenal incidentalomas is discussed. Very important issue is to distinguish between benign and malignant lesions and between adenomas and non-adenomas. The accuracy of CT, MR, and fine needle aspiration cytology in distinguishing between adenomas from non-adenomas is comparable, in general not exceeding 90 %. Particular characteristics of particular adrenal tumours are discussed. From the relationship between the tumour size and probability of malignancy, current recommendations are derived, that non-functioning tumours smaller than 4 cm are indicated for further follow-up, size over 6 cm is indication for adrenalectomy and in tumours between 4-6 cm decision process is complex.

Keywords: adrenals; tumour; incidentaloma; diagnosis; treatment

Received: January 22, 2007; Published: July 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kršek M. Adrenal incidentalomas. Vnitr Lek. 2007;53(7-8):821-825.
Download citation

References

  1. Chidiac RM, Aron DC. Incidentalomas. A disease of modern technology. Endocrinol Metab Clin North Am 1997; 26: 233-253. Go to original source... Go to PubMed...
  2. Griffing G. A-I-D-S: The new endocrine epidemic (Editorial comment). J Clin Endocrinol Metab 1994; 79: 1530-1531. Go to original source...
  3. Kloos RT, Gross MD, Francis IR et al. Incidentally discovered adrenal masses. Endocr Rev 1995; 16: 460-464. Go to original source...
  4. Barzon F, Fallo F, Sonino N et al. Prevalence and the natural course of adrenal incidentaloma. NIH State-of-the Science Conference on Management of the Clinically Inapparent Adrenal Mass (Incidentaloma), NIH, Bethesda, Maryland, February 4-6, 2002, 27.
  5. Mantero F, Arnaldi G. Investigation protocol: adrenal enlargement. Clin Endocrinol 1999; 50: 141-146. Go to original source... Go to PubMed...
  6. Mantero F, Terzolo M, Arnaldi G et al. On behalf of the study group on adrenal tumours of the Italian Society of Endocrinology. J Clin Endocrinol Metab 2000; 85: 637-644. Go to original source...
  7. Reincke M. Subclinical Cushing's syndrome. Endocrinol Metab Clin North Am 2000; 29: 43-46. Go to original source... Go to PubMed...
  8. Kršek M, Hána V et al. Cushingův syndrom. Praha: Galén 2006.
  9. Widimský J jr. Mineralokortikoidní hypertenze. In: Marek J et al (Ed). Endokrinní hypertenze. Praha: Galén 2004: 47-70.
  10. Pacák K. Nové postupy v diagnostice a léčbě feochromocytomu a pseudofeochromocytomu. In: Marek J et al (Ed). Endokrinní hypertenze. Praha: Galén 2004: 117-160.
  11. Kršek M. Náhodně zjištěné tumory nadledvin. Postgraduální medicína. Mimořádná příloha 2006; 20-27.
  12. Balk EM. The performance for evaluating incidentaloma. NIH State-if-the Science Conference on Management of the Clinically Inapparent Adrenal Mass (Incidentaloma). NIH, Bethesda, Maryland, February 4-6, 2002: 35-37.
  13. Grumbach MM, Biller BMK, Braunstein GD et al. Management of the clinically inaparent adrenal mass (incidentaloma). Ann Intern Med 2003; 138: 424-429. Go to original source... Go to PubMed...
  14. Kršek M, Matějovská H. Diferenciální diagnóza incidentalomů nadledvin a úloha zobrazovacích metod. Vnitř Lék 2002; 48: 409-415. Go to PubMed...
  15. Barzon L, Scaroni C, Sonino N et al. Risk factors and long-term follow-up of adrenal incidentalomas. J Clin Endocrinol Metab 1999; 84: 520-526. Go to original source...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.